152 related articles for article (PubMed ID: 10653465)
1. Management of hepatitis C in the hemophilia patient.
Fried MW
Am J Med; 1999 Dec; 107(6B):85S-89S. PubMed ID: 10653465
[TBL] [Abstract][Full Text] [Related]
2. Hepatitis C in haemophilia: lights and shadows.
Rumi MG; De Filippi F; Santagostino E; Colombo M
Haemophilia; 2004 Oct; 10 Suppl 4():211-5. PubMed ID: 15479400
[TBL] [Abstract][Full Text] [Related]
3. Interferon-alpha treatment of chronic hepatitis C in children with hemophilia.
Ko JS; Choe YH; Kim EJ; Lee EH; Jang JJ; Seo JK
J Pediatr Gastroenterol Nutr; 2001 Jan; 32(1):41-4. PubMed ID: 11176323
[TBL] [Abstract][Full Text] [Related]
4. Update on liver disease in hemophilia patients.
Kessler CM
Semin Hematol; 2006 Jan; 43(1 Suppl 1):S13-7. PubMed ID: 16427378
[TBL] [Abstract][Full Text] [Related]
5. Peginterferon alfa-2a plus ribavirin for hemophilic patients with chronic hepatitis C virus infection in Taiwan.
Lin JA; Chen YC; Cheng SN; Chen PJ; Chu HC; Hsieh TY; Shih YL
J Formos Med Assoc; 2014 Oct; 113(10):727-33. PubMed ID: 24231092
[TBL] [Abstract][Full Text] [Related]
6. Peginterferon Alfa-2a plus ribavirin versus interferon alfa-2a plus ribavirin for chronic hepatitis C in HIV-coinfected persons.
Chung RT; Andersen J; Volberding P; Robbins GK; Liu T; Sherman KE; Peters MG; Koziel MJ; Bhan AK; Alston B; Colquhoun D; Nevin T; Harb G; van der Horst C;
N Engl J Med; 2004 Jul; 351(5):451-9. PubMed ID: 15282352
[TBL] [Abstract][Full Text] [Related]
7. Undetectable hepatitis C virus RNA at week 4 as predictor of sustained virological response in HIV patients with chronic hepatitis C.
Martin-Carbonero L; Nuñez M; Mariño A; Alcocer F; Bonet L; García-Samaniego J; López-Serrano P; Cordero M; Portu J; Soriano V
AIDS; 2008 Jan; 22(1):15-21. PubMed ID: 18090387
[TBL] [Abstract][Full Text] [Related]
8. Treatment of chronic hepatitis C in haemophilic patients with interferon and ribavirin: a meta-analysis.
Franchini M; Mengoli C; Veneri D; Mazzi R; Lippi G; Cruciani M
J Antimicrob Chemother; 2008 Jun; 61(6):1191-200. PubMed ID: 18356154
[TBL] [Abstract][Full Text] [Related]
9. New approaches to the management of hepatitis C in haemophilia in 2012.
Zoulim F; Bailly F
Haemophilia; 2012 Jul; 18 Suppl 4():28-33. PubMed ID: 22726079
[TBL] [Abstract][Full Text] [Related]
10. A case of successful hepatitis C virus eradication by 24 weeks of telaprevir-based triple therapy for a hemophilia patient with hepatitis C virus/human immunodeficiency virus co-infection who previously failed pegylated interferon-α and ribavirin therapy.
Murata M; Furusyo N; Ogawa E; Mitsumoto F; Hiramine S; Ikezaki H; Takayama K; Shimizu M; Toyoda K; Kainuma M; Hayashi J
J Infect Chemother; 2014 May; 20(5):320-4. PubMed ID: 24477330
[TBL] [Abstract][Full Text] [Related]
11. Hepatitis C (HCV) genotype and viral titer distribution among Argentinean hemophilic patients in the presence or absence of human immunodeficiency virus (HIV) co-infection.
Picchio GR; Nakatsuno M; Boggiano C; Sabbe R; Corti M; Daruich J; Pérez-Bianco R; Tezanos-Pinto M; Kokka R; Wilber J; Mosier D
J Med Virol; 1997 Jun; 52(2):219-25. PubMed ID: 9179772
[TBL] [Abstract][Full Text] [Related]
12. [Hepatitis C].
Moradpour D; Blum HE
Ther Umsch; 2004 Aug; 61(8):493-8. PubMed ID: 15457965
[TBL] [Abstract][Full Text] [Related]
13. NIH Consensus Statement on Management of Hepatitis C: 2002.
NIH Consens State Sci Statements; 2002 Jun 10-12; 19(3):1-46. PubMed ID: 14768714
[TBL] [Abstract][Full Text] [Related]
14. Hepatitis C virus-RNA clearance in HIV-coinfected patients with chronic hepatitis C treated with pegylated interferon plus ribavirin.
Soriano V; Núñez M; Camino N; Maida I; Barreiro P; Romero M; Martin-Carbonero L; Garcia-Samaniego J; González-Lahoz J
Antivir Ther; 2004 Aug; 9(4):505-9. PubMed ID: 15456081
[TBL] [Abstract][Full Text] [Related]
15. Peginterferon Alfa-2a plus ribavirin for chronic hepatitis C virus infection in HIV-infected patients.
Torriani FJ; Rodriguez-Torres M; Rockstroh JK; Lissen E; Gonzalez-García J; Lazzarin A; Carosi G; Sasadeusz J; Katlama C; Montaner J; Sette H; Passe S; De Pamphilis J; Duff F; Schrenk UM; Dieterich DT;
N Engl J Med; 2004 Jul; 351(5):438-50. PubMed ID: 15282351
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of pegylated interferon and ribavirin combination therapy for patients with hepatitis C virus infection after curative resection or ablation for hepatocellular carcinoma--A retrospective multicenter study.
Harada N; Hiramatsu N; Oze T; Tatsumi T; Hayashi N; Takehara T
J Med Virol; 2015 Jul; 87(7):1199-206. PubMed ID: 25772024
[TBL] [Abstract][Full Text] [Related]
17. Response to pegylated interferon plus ribavirin in HIV-infected patients with chronic hepatitis C due to genotype 4.
Martín-Carbonero L; Puoti M; García-Samaniego J; De Luca A; Losada E; Quinzan G; Bruno R; Mariño A; González M; Núñez M; Soriano V
J Viral Hepat; 2008 Oct; 15(10):710-5. PubMed ID: 18637070
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis C virus and human immunodeficiency virus: clinical issues in coinfection.
Dieterich DT
Am J Med; 1999 Dec; 107(6B):79S-84S. PubMed ID: 10653464
[TBL] [Abstract][Full Text] [Related]
19. Sexually transmitted acute infection with a clustered genotype 4 hepatitis C virus in HIV-1-infected men and inefficacy of early antiviral therapy.
Serpaggi J; Chaix ML; Batisse D; Dupont C; Vallet-Pichard A; Fontaine H; Viard JP; Piketty C; Rouveix E; Rouzioux C; Weiss L; Pol S
AIDS; 2006 Jan; 20(2):233-40. PubMed ID: 16511416
[TBL] [Abstract][Full Text] [Related]
20. Treatment of chronic hepatitis C in special groups.
Pol S; Zylberberg H; Fontaine H; Bréchot C
J Hepatol; 1999; 31 Suppl 1():205-9. PubMed ID: 10622589
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
